These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27411355)

  • 41. A new role for myeloid HO-1 in the innate to adaptive crosstalk and immune homeostasis.
    Koliaraki V; Kollias G
    Adv Exp Med Biol; 2011; 780():101-11. PubMed ID: 21842368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1-IRF3 signaling axis.
    Seo M; Lee SO; Kim JH; Hong Y; Kim S; Kim Y; Min DH; Kong YY; Shin J; Ahn K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14390-14395. PubMed ID: 27911820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The EF-Hand Protein CALML6 Suppresses Antiviral Innate Immunity by Impairing IRF3 Dimerization.
    Wang Z; Sheng C; Yao C; Chen H; Wang D; Chen S
    Cell Rep; 2019 Jan; 26(5):1273-1285.e5. PubMed ID: 30699354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SAMHD1 deficient human monocytes autonomously trigger type I interferon.
    Martinez-Lopez A; Martin-Fernandez M; Buta S; Kim B; Bogunovic D; Diaz-Griffero F
    Mol Immunol; 2018 Sep; 101():450-460. PubMed ID: 30099227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA damage induces a SAMHD1-mediated block to the infection of macrophages by HIV-1.
    Jáuregui P; Landau NR
    Sci Rep; 2018 Mar; 8(1):4153. PubMed ID: 29515139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MIP-T3 is a negative regulator of innate type I IFN response.
    Ng MH; Ho TH; Kok KH; Siu KL; Li J; Jin DY
    J Immunol; 2011 Dec; 187(12):6473-82. PubMed ID: 22079989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1.
    Saitoh T; Tun-Kyi A; Ryo A; Yamamoto M; Finn G; Fujita T; Akira S; Yamamoto N; Lu KP; Yamaoka S
    Nat Immunol; 2006 Jun; 7(6):598-605. PubMed ID: 16699525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OTUD1 Negatively Regulates Type I IFN Induction by Disrupting Noncanonical Ubiquitination of IRF3.
    Zhang Z; Wang D; Wang P; Zhao Y; You F
    J Immunol; 2020 Apr; 204(7):1904-1918. PubMed ID: 32075857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry.
    Hare DN; Collins SE; Mukherjee S; Loo YM; Gale M; Janssen LJ; Mossman KL
    J Virol; 2015 Dec; 90(6):3018-27. PubMed ID: 26719279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.
    Gutiérrez-Chamorro L; Felip E; Bernat-Peguera A; Ezeonwumelu IJ; Teruel I; Martínez-Cardús A; Clotet B; Riveira-Muñoz E; Romeo M; Margelí M; Ballana E
    Front Immunol; 2023; 14():1112761. PubMed ID: 36845138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity.
    Li Z; Huan C; Wang H; Liu Y; Liu X; Su X; Yu J; Zhao Z; Yu XF; Zheng B; Zhang W
    EMBO Rep; 2020 Jan; 21(1):e47528. PubMed ID: 31797533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irf3 from mandarin fish thymus initiates interferon transcription.
    Chen X; Shen Y; Wu M; Zhao J
    Fish Physiol Biochem; 2019 Feb; 45(1):133-144. PubMed ID: 30056593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A-B55α holoenzymes during mitotic exit.
    Schott K; Fuchs NV; Derua R; Mahboubi B; Schnellbächer E; Seifried J; Tondera C; Schmitz H; Shepard C; Brandariz-Nuñez A; Diaz-Griffero F; Reuter A; Kim B; Janssens V; König R
    Nat Commun; 2018 Jun; 9(1):2227. PubMed ID: 29884836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis.
    An N; Ge Q; Shao H; Li Q; Guo F; Liang C; Li X; Yi D; Yang L; Cen S
    Front Immunol; 2022; 13():1007718. PubMed ID: 36532074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma.
    Li Y; Gao Y; Jiang X; Cheng Y; Zhang J; Xu L; Liu X; Huang Z; Xie C; Gong Y
    J Transl Med; 2022 Dec; 20(1):628. PubMed ID: 36578072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of T592 phosphomimetic mutations on tetramer stability and dNTPase activity of SAMHD1 can not explain the retroviral restriction defect.
    Bhattacharya A; Wang Z; White T; Buffone C; Nguyen LA; Shepard CN; Kim B; Demeler B; Diaz-Griffero F; Ivanov DN
    Sci Rep; 2016 Aug; 6():31353. PubMed ID: 27511536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human OTUD6B positively regulates type I IFN antiviral innate immune responses by deubiquitinating and stabilizing IRF3.
    Wang J; Zheng H; Dong C; Xiong S
    mBio; 2023 Oct; 14(5):e0033223. PubMed ID: 37650650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IFN regulatory factor 3 of golden pompano and its NLS domain are involved in antibacterial innate immunity and regulate the expression of type I interferon (IFNa3).
    Sun Y; Cao Z; Zhang P; Wei C; Li J; Wu Y; Zhou Y
    Front Immunol; 2023; 14():1128196. PubMed ID: 36817435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SAMHD1 associates with inflammation and vasculitis in paediatric-onset systemic lupus erythematosus.
    Zhao X; Li C; Li S; Zhang J; Kuang W; Deng J; Tan X; Li C; Wang J
    Clin Exp Rheumatol; 2022 Sep; 40(9):1801-1807. PubMed ID: 35579088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.